MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
LeMaitre Vascular General and Administrative Expenses 2011-2026 | LMAT
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses LeMaitre Vascular
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.3 M | 31.8 M | 28.7 M | 25.5 M | 22.5 M | 19.1 M | 17.7 M | 17 M | 14.4 M | 14 M | 13.9 M | 12.6 M | 11 M | 11.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.3 M | 11 M | 19.7 M |
Quarterly General and Administrative Expenses LeMaitre Vascular
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 M | 10.4 M | 10.5 M | 8.93 M | 8.82 M | 9.01 M | 7.74 M | 7.72 M | 7.93 M | - | 7.23 M | 7.33 M | 7.25 M | - | 6 M | 6.2 M | 6.54 M | - | 5.9 M | 5.33 M | 5.19 M | - | 4.55 M | 4.53 M | 4.94 M | - | 3.98 M | 4.55 M | 4.7 M | - | 4.56 M | 3.75 M | 4.55 M | - | 3.6 M | 3.41 M | 3.34 M | - | 3.46 M | 3.3 M | 3.62 M | - | 3.76 M | 3.3 M | 3.32 M | - | 3.28 M | 3.07 M | 2.88 M | - | 2.89 M | 2.72 M | 2.67 M | - | 2.8 M | 2.87 M | 2.85 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.8 M | 2.67 M | 5.24 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 202.09 | -0.31 % | $ 58.1 B |  USA |
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M | USA |
 |
Baxter International
BAX
|
2.97 B | $ 20.07 | -4.72 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
ICU Medical
ICUI
|
639 M | $ 151.18 | -1.18 % | $ 3.69 B | USA |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 8.77 | 1.15 % | $ 181 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.87 | 3.89 % | $ 268 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 8.45 | 6.56 % | $ 170 M | USA |
 |
Alcon
ALC
|
251 M | $ 80.71 | 0.72 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
291 M | $ 37.21 | -10.25 % | $ 1.75 B | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 130.93 | -5.75 % | $ 6.98 B | USA |
 |
electroCore
ECOR
|
27.2 M | $ 6.35 | 12.79 % | $ 35 K | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 83.15 | -3.74 % | $ 4.84 B | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 10.16 | 3.04 % | $ 415 M | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 83.29 | -0.19 % | $ 16.6 B | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 82.57 | 0.66 % | $ 4.16 B | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.62 | -2.13 % | $ 26.3 M | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 111.12 | -1.6 % | $ 5.38 B | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
419 M | $ 168.23 | -6.24 % | $ 5.25 B | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.7 | 2.66 % | $ 201 M | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 572.2 | -2.39 % | $ 203 B | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 2.13 | 2.15 % | $ 21.7 M |  Israel |
 |
Nephros
NEPH
|
8.91 M | $ 4.58 | -4.78 % | $ 47.6 M | USA |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.29 | -1.09 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 23.47 | -0.68 % | $ 4.04 B | USA |
 |
Predictive Oncology
POAI
|
7.42 M | $ 6.84 | 0.22 % | $ 37.3 M | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 43.19 | 3.46 % | $ 142 M | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 14.47 | -0.17 % | $ 695 M | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 169.22 | 1.44 % | $ 9.43 M | USA |
 |
ResMed
RMD
|
739 M | $ 257.08 | 1.8 % | $ 37.6 B | USA |
 |
BioLife Solutions
BLFS
|
40.5 M | $ 24.15 | -2.86 % | $ 1.11 B | USA |
 |
STERIS plc
STE
|
1.33 B | $ 260.03 | 1.31 % | $ 25.6 B | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.56 | 1.79 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.76 | -1.91 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 22.06 | -0.26 % | $ 1.08 B | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 109.07 | -3.33 % | $ 5.11 B | USA |
 |
Utah Medical Products
UTMD
|
11 M | $ 60.1 | 0.33 % | $ 218 M | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 272.1 | -1.18 % | $ 19.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 12.44 | -2.7 % | $ 2.53 B | USA |